Comparison of a multiple daily injection regimen with once-daily insulin glargine basal insulin and mealtime lispro, to continuous subcutaneous insulin infusion: A randomised, open, parallel study

被引：0
|
作者：
Bolli, GB
Capani, F
Home, PD
Kerr, D
Thomas, R
Torlone, E
Selam, JL
Sola-Gazagnes, A
Vitacolonna, E
机构：
来源：
DIABETES | 2004年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A107 / A108
页数：2
相关论文
共 50 条
  • [31] FDA approves once-daily basal insulin
    不详
    NURSE PRACTITIONER, 2015, 40 (06): : 56 - 56
  • [32] Insulin lispro low mixture twice daily vs basal insulin glargine once daily and prandial insulin lispro once daily as insulin intensification strategies in patients with type 2 diabetes: A Latin American subpopulation analysis of a randomized trial
    Douglas Eugenio Barbieri
    Ran Duan
    Jorge Gross
    Bruno Linetzky
    Janaina Martins De Lana
    Arturo Rojas
    Georgina Sposetti
    Oded Stempa
    Angel Rodriguez
    Diabetology & Metabolic Syndrome, 7 (Suppl 1):
  • [33] Equivalence of once-daily and twice-daily insulin glargine administration
    Burge, MR
    Schroeder, E
    DIABETOLOGIA, 2004, 47 : A305 - A305
  • [34] A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine
    Doyle, EA
    Weinzimer, SA
    Steffen, AT
    Ahern, JAH
    Vincent, M
    Tamborlane, WV
    DIABETES CARE, 2004, 27 (07) : 1554 - 1558
  • [35] Switching from Twice-Daily Basal Insulin Injections to Once-Daily Insulin Degludec Injection for Basal-Bolus Insulin Regimen in Japanese Patients with Type 1 Diabetes: A Pilot Study
    Tosaka, Yuka
    Kanazawa, Akio
    Ikeda, Fuki
    Iida, Mayu
    Sato, Junko
    Matsumoto, Kazuhisa
    Uchida, Toyoyoshi
    Tamura, Yoshifumi
    Ogihara, Takeshi
    Mita, Tomoya
    Shimizu, Tomoaki
    Goto, Hiromasa
    Ohmura, Chie
    Fujitani, Yoshio
    Watada, Hirotaka
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2015, 2015
  • [36] Continuous subcutaneous insulin infusion (CSII)of insulin aspart versus multiple daily injection of insulin aspart/insulin glargine in type 1 diabetic patients previously treated with CSII
    Hirsch, IB
    Bode, BW
    Garg, S
    Lane, WS
    Süssman, A
    Hu, P
    Santiago, OM
    Kolaczynski, J
    DIABETES CARE, 2005, 28 (03) : 533 - 538
  • [37] Efficacy of once daily insulin glargine as basal insulin replacement in insulin-deficient diabetes
    Meneghini, Luigi F.
    Wick, Allison K.
    Sparrow-Bodenmiller, Jane
    Avila, Ana M.
    DIABETES, 2006, 55 : A125 - A125
  • [38] Continuous subcutaneous insulin infusion versus multiple daily injections
    Retnakaran, R
    Hochman, J
    DeVries, JH
    Hanaire-Broutin, H
    Heine, RJ
    Melki, V
    Zinman, B
    DIABETES CARE, 2004, 27 (11) : 2590 - 2596
  • [39] Continuous subcutaneous insulin infusion versus multiple daily injections
    Karagianni, P.
    Sampanis, Ch
    Katsoulis, C.
    Miserlis, Gr
    Polyzos, S.
    Zografou, V
    Stergiopoulos, S.
    Douloumbakas, I
    Zamboulis, Ch
    HIPPOKRATIA, 2009, 13 (02) : 93 - 96
  • [40] Insulin lispro low mixture twice daily versus basal insulin glargine once daily and prandial insulin lispro once daily in patients with type 2 diabetes mellitus requiring insulin intensification—a randomized phase IV trial: Indian subpopulation analyses
    K. M. Prasanna Kumar
    Sanjiv Shah
    Parag Shah
    Simon Cleall
    Steve Chen
    Shweta Uppal
    International Journal of Diabetes in Developing Countries, 2017, 37 : 116 - 123
12345